HVR Cardio raised €11M in a Series B round in Jan 2023. The company is based in Espoo, Finland. Investors in the round: Innovestor Life Science Fund, Tesi. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €11M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.